We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Woodcock to Congress: FDA Is Not a Drug Price Regulator, GDUFA Progress on Track
Woodcock to Congress: FDA Is Not a Drug Price Regulator, GDUFA Progress on Track
The FDA is not in the business of regulating drug prices, CDER Director Janet Woodcock told a Senate committee Jan. 28, pushing back against criticism that the FDA should tackle rising drug prices.